Segra International CEO Todd McMurray discusses the company's tissue culture capabilities as a superior alternative to traditional cannabis cloning methods. Tissue culture dominates most modern commercial agriculture, and Segra is bringing the low risk, economically efficient method to cannabis cultivators. Segra International plans to go public in the near future.